Therapeutic Asset Ratings
181 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Autologous Cd19/Cd22 Dual-Target Car-T Module
plasma cell myeloma
Beijing Biotech
P1/2
CC
(47)
Autologous Cd33/Cd123 Dual-Target Car-T Module
B-cell acute lymphoblastic leukemia
Beijing Biotech
P1/2
CC
(47)
Autologous Cd33/Cd123 Dual-Target Car-T Module
B-cell non-Hodgkin lymphoma
Beijing Biotech
P1/2
CC
(47)
Autologous Cd33/Cd123 Dual-Target Car-T Module
plasma cell myeloma
Beijing Biotech
P1/2
CC
(47)
Autologous Cd33/Cll1 Dual-Target Car-T Module
B-cell acute lymphoblastic leukemia
Beijing Biotech
P1/2
CC
(47)
Autologous Cd33/Cll1 Dual-Target Car-T Module
B-cell non-Hodgkin lymphoma
Beijing Biotech
P1/2
CC
(47)
Autologous Cd33/Cll1 Dual-Target Car-T Module
plasma cell myeloma
Beijing Biotech
P1/2
CC
(47)
Autologous Cd5/Cd7 Dual-Target Car-T Module
B-cell acute lymphoblastic leukemia
Beijing Biotech
P1/2
CC
(47)
Autologous Cd5/Cd7 Dual-Target Car-T Module
B-cell non-Hodgkin lymphoma
Beijing Biotech
P1/2
CC
(47)
Autologous Cd5/Cd7 Dual-Target Car-T Module
plasma cell myeloma
Beijing Biotech
P1/2
CC
(47)
Autologous Dual-Target Car-T Cells Selected From The Predefined Target Library.
metastatic neoplasm
Beijing Biotech
P1/2
CC
(47)
Cyclophosphamide
gastric adenocarcinoma
Beijing Biotech
P1/2
CC
(47)
Cyclophosphamide
cortical thymoma
Beijing Biotech
P1/2
CC
(47)
Cyclophosphamide
metastatic neoplasm
Beijing Biotech
P1/2
CC
(47)
Cyclophosphamide
Unresectable Locally Advanced
Beijing Biotech
P1/2
CC
(47)
Cyclophosphamide
Unresectable Locally Advanced or Metastatic Disease
Beijing Biotech
P1/2
CC
(47)
Dual-Target Car-Nk Cell Product
Fallopian Tube Carcinoma
Beijing Biotech
P1/2
CC
(47)
Dual-Target Car-Nk Cells
gastric adenocarcinoma
Beijing Biotech
P1/2
CC
(47)
Dual-Target Car-Nk Cells
gastroesophageal junction adenocarcinoma
Beijing Biotech
P1/2
CC
(47)
Dual-Target Car-Nk Cells
breast cancer
Beijing Biotech
P1/2
CC
(47)
Eb-Car30-Nk
cortical thymoma
Beijing Biotech
P1/2
CC
(47)
Eb-Car5-Nk
cortical thymoma
Beijing Biotech
P1/2
CC
(47)
Eb-Carmsln-Nk
cortical thymoma
Beijing Biotech
P1/2
CC
(47)
Eb-Dnk101 Dual-Targeting Car-Nk Cells
Unresectable Locally Advanced
Beijing Biotech
P1/2
CC
(47)
Eb-Dnk101 Dual-Targeting Car-Nk Cells
Unresectable Locally Advanced or Metastatic Disease
Beijing Biotech
P1/2
CC
(47)
Showing 76 to 100 of 181 assets
Previous
Page 4 of 8
Next